Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
November 17, 2003
- ON THE MOVE
November 17, 2003
- DIAGNOSTIC NEWS IN BRIEF
November 17, 2003
- Societies Request Exemption of Expensive Drugs from Flat-sum Reimbursement System
November 17, 2003
- OTC NEWS IN BRIEF
November 17, 2003
- Daiichi: Cravit, Artist Contribute to Good Sales
November 17, 2003
- REGULATORY NEWS IN BRIEF
November 10, 2003
- Support for Bungyo Stronger in Patients Who Have Experienced It
November 10, 2003
- MEDICAL DEVICE NEWS IN BRIEF
November 10, 2003
- BULLETIN
November 10, 2003
- WORLD NEWS IN BRIEF
November 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 10, 2003
- Japanese Healthcare Q&A (3)
November 10, 2003
- Hayashibara Develops Peptide Antigens for Transmucosal Administration
November 10, 2003
- Nearly 70% of Women Worry about Adverse Reactions of Oral Contraceptives
November 10, 2003
- Long-term Monitoring Required after H. Pylori Eradication
November 10, 2003
- Debiopharm Preparing to Enter Japanese Market: Dr Mauvernay
November 10, 2003
- Crucial Info Should Be Printed Larger on Drug Labels: Study
November 10, 2003
- FJPWA Management Seminar
November 10, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
November 10, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…